The chicken chorioallantoic membrane (CAM) is a simple, highly vascularized
extraembryonic membrane, which performs multiple functions during embryonic …

Simple Summary The chorioallantoic membrane (CAM) model is an alternative in vivo test
system for the study of hallmarks of cancer such as angiogenesis, tumor growth, immune …

The majority of ovarian cancer patients present with advanced disease and despite
aggressive treatment, prognosis remains poor. Significant improvement in ovarian cancer …

The chick chorioallantoic membrane (CAM) assay model of angiogenesis has been
highlighted as a relatively quick, low cost and effective model for the study of pro-angiogenic …

Survival rates of osteosarcoma patients could not be significantly improved by conventional
chemotherapeutic treatment regimens since the introduction of high-dose chemotherapy 35 …

The chick chorioallantoic membrane (CAM) begins to develop by day 7 after fertilization and
matures by day 12. The CAM is naturally immunodeficient and highly vascularized, making it …

Sarcoma is a very rare disease that is heterogeneous in nature, all hampering the
development of new therapies. Sarcoma patients are ideal candidates for personalized …

Recently, it has been shown that silver nanoparticles (AgNPs) provide a unique approach to
the treatment of tumors, especially those of neuroepithelial origin. Thus, the aim of this study …

Background Neuroblastoma is a paediatric cancer that despite multimodal therapy still has a
poor outcome for many patients with high risk tumours. Retinoic acid (RA) promotes …

Tumor cells trigger angiogenesis through overexpression of various angiogenic factors
including vascular endothelial growth factor (VEGF) and angiopoietin 1 (Ang1). Therefore …